Farm to shelf, low-cost high-margin medical cannabis

Specifically targeted at helping veterans and first responders with PTSD, Allied Health leverages the most fertile and logistically convenient land in South America with Canadian technology to bring low-cost high-margin medical cannabis to the global market.

Why Invest?

If you are a survivor of PTSD please go to the Allied Foundation page to learn more about our model of care.
Learn More About Allied Foundation Recovery Program

Allied Corp. is dedicated to helping people. As a research and development company, our focus is on creating and providing targeted cannabinoid health solutions for today’s medical issues. One of our top R&D priorities is developing effective Post Traumatic Stress Disorder (PTSD)/Post Traumatic Stress Injury (PTSI) solutions.

Why Invest?

With more than 25 countries legalized, the medical cannabis market is expected to grow from $11bn to $56bn by 2025. South America is positioned to become the new global supply source as global demand will outstrip supply. Allied will be ready.

Low Cost, High Quality, High Margin Advantage

Low capex – $0.09-0.15 per gram of dry flower vs average of $1.52/ gram in Canada. Low-cost, high-margin model.

Massive Ability To Scale

We expect over 10 million sq. ft in Colombia cultivation. We have the ability to scale to much more.

Forecast to produce approximately 85,000 kgs of product in 2020 and approximately 420,000 kgs in 2021.

Technology & Products

Nano-based technology provides a much more standardized delivery of cannabinoids into the body. Along with pre-clinical research from Israel, we plan to have several Pharma and Neutra products to market that serve veterans and first responders.

Experienced Management Team

Decades of growing and extraction expertise. Strong regional and agricultural specialists in each country. Experienced business support team active in market support and production execution.

If you need more information or have any questions, let’s talk.

Connect with investor relations

Our Story

Our mission is to help people around the world by creating and providing targeted cannabinoid health solutions using cutting-edge pharmaceutical R&D, innovative plant-based production, and unique development of therapeutic products.



Our operations span from grow operations in South America to R&D of targeted cannabinoid health solutions in Canada for today’s medical issues. Our end-to-end business model enables Allied to bring unique and effective products to market.


Investor Information

Allied Health Foundation

Our charitable foundation supports in-person healing retreats supported by online connection to an anonymous peer-community to provide on-going care and support for veterans, police, fire, and emergency health first-responders.


Sign up to our newsletter and get first access to the latest investor news, events, and other important information related to Allied Health.

Keep Informed